• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙通道阻滞剂:碳酸酐酶 I 和 II 同工酶的分子对接和抑制研究。

Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes.

机构信息

Faculty of Pharmacy, Department of Biochemistry, Erzincan Binali Yıldırım University, Erzincan, Turkey.

Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Turkey.

出版信息

J Biomol Struct Dyn. 2021 Mar;39(5):1672-1680. doi: 10.1080/07391102.2020.1736631. Epub 2020 Mar 9.

DOI:10.1080/07391102.2020.1736631
PMID:32107977
Abstract

Carbonic anhydrases (CAs) are potent dehydration of carbonic acid and catalyst of the reversible hydration of carbon dioxide. Here, CA I and CA II was purified from human erythrocytes using the simple chromatographic method and determined the interactions between some calcium channel blockers and the enzymes. Molecular docking studies were performed these compounds. It was found that calcium channel blockers (nimodipine, nilvadipine, nitrendipine, isradipine, and nifedipine) exhibit potential inhibitor properties for hCA I and hCA II. values of hCA I were in the range of 9.24-58.00 μM, and constants were in the range of 7.60 ± 2.68-35.92 ± 16.01 μM. values of hCA II were in the range of 70.00-138.60 μM, and constants were in the range of 48.30 ± 9.81-162.35 ± 20.47 μM. Nimodipine presented the highest docking score and had competitive inhibition, the benzene and pyridine rings were found to enter the cavity for hCA I. Nifedipine and isradipine did not affect hCA II. Among these drugs, nitrendipine was found to be the most potent inhibitor for hCA I and nimodipine for hCA II. These compounds may be useful for CA inhibitors.Communicated by Ramaswamy H. Sarma.

摘要

碳酸酐酶(CA)是碳酸的高效脱水酶和二氧化碳可逆水合作用的催化剂。本文采用简单的色谱法从人红细胞中纯化 CA I 和 CA II,并测定了几种钙通道阻滞剂与酶之间的相互作用。对这些化合物进行了分子对接研究。结果表明,钙通道阻滞剂(尼莫地平、尼伐地平、硝苯地平、异博定和硝苯地平)对 hCA I 和 hCA II 具有潜在的抑制特性。hCA I 的 值在 9.24-58.00 μM 范围内, 常数在 7.60 ± 2.68-35.92 ± 16.01 μM 范围内。hCA II 的 值在 70.00-138.60 μM 范围内, 常数在 48.30 ± 9.81-162.35 ± 20.47 μM 范围内。尼莫地平呈现出最高的对接评分和竞争性抑制,苯环和吡啶环被发现进入 hCA I 的腔。硝苯地平和异博定不影响 hCA II。在这些药物中,尼群地平被发现是 hCA I 的最有效抑制剂,尼莫地平是 hCA II 的抑制剂。这些化合物可能对 CA 抑制剂有用。Ramasesh H. Sarma 通讯。

相似文献

1
Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes.钙通道阻滞剂:碳酸酐酶 I 和 II 同工酶的分子对接和抑制研究。
J Biomol Struct Dyn. 2021 Mar;39(5):1672-1680. doi: 10.1080/07391102.2020.1736631. Epub 2020 Mar 9.
2
Investigation of and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II.研究几种新型咔唑席夫碱对人碳酸酐酶同工酶 I 和 II 的作用及在计算机上的效果。
J Biomol Struct Dyn. 2022 Sep;40(15):6965-6973. doi: 10.1080/07391102.2021.1892527. Epub 2021 Mar 1.
3
Investigation of the effects of some pesticides on carbonic anhydrase isoenzymes.研究某些农药对碳酸酐酶同工酶的影响。
J Mol Recognit. 2023 Sep;36(9):e3048. doi: 10.1002/jmr.3048. Epub 2023 Aug 8.
4
Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies.通过动力学和分子模拟研究评估一些噻吩基磺胺类化合物作为人红细胞中碳酸酐酶 I 和 II 同工酶的有效抑制剂。
Pharmacol Rep. 2020 Dec;72(6):1738-1748. doi: 10.1007/s43440-020-00149-4. Epub 2020 Aug 3.
5
The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.三甲氧基茚满衍生物对人碳酸酐酶同工酶I和II(hCA I和II)的抑制作用。
J Enzyme Inhib Med Chem. 2016;31(1):152-7. doi: 10.3109/14756366.2015.1014476. Epub 2015 Feb 20.
6
The effects of some bromophenols on human carbonic anhydrase isoenzymes.某些溴酚对人碳酸酐酶同工酶的影响。
J Enzyme Inhib Med Chem. 2016 Aug;31(4):603-7. doi: 10.3109/14756366.2015.1054820. Epub 2015 Jul 2.
7
Inhibition Profiles and Molecular Docking Analysis of Benzohydrazide Derivatives on Red Blood Cell Carbonic Anhydrases Isozymes.苯甲酰肼衍生物对红细胞碳酸酐酶同工酶的抑制谱和分子对接分析。
Curr Comput Aided Drug Des. 2022;18(5):381-392. doi: 10.2174/1573409918666220818114505.
8
The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity.某些查耳酮对乙酰胆碱酯酶和碳酸酐酶活性的影响。
Drug Chem Toxicol. 2019 Nov;42(6):634-640. doi: 10.1080/01480545.2018.1463242. Epub 2018 Jun 4.
9
Synthesis and evaluation of sulfonamide-bearing thiazole as carbonic anhydrase isoforms hCA I and hCA II.含磺酰胺基噻唑作为碳酸酐酶同工型hCA I和hCA II的合成与评价
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1300-5. doi: 10.3109/14756366.2015.1128426. Epub 2016 Jan 8.
10
Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates.氨基甲酰酯和磺酰胺基甲酰酯对碳酸酐酶和乙酰胆碱酯酶的抑制作用。
J Enzyme Inhib Med Chem. 2015 Apr;30(2):316-20. doi: 10.3109/14756366.2014.928704. Epub 2014 Jun 25.

引用本文的文献

1
Exploring the efficacy of some biologically active compounds as anti-hypertensive drugs: an insightful evaluation through DFT, molecular docking and molecular dynamics simulations.探索某些生物活性化合物作为抗高血压药物的疗效:通过密度泛函理论(DFT)、分子对接和分子动力学模拟进行的深入评估。
In Silico Pharmacol. 2024 Dec 24;13(1):4. doi: 10.1007/s40203-024-00291-4. eCollection 2025.
2
Depression of Ca1.2 activation and expression in mast cells ameliorates allergic inflammation diseases.肥大细胞中Ca1.2激活和表达的抑制可改善过敏性炎症疾病。
J Pharm Anal. 2024 Nov;14(11):101149. doi: 10.1016/j.jpha.2024.101149. Epub 2024 Nov 14.
3
Inhibitory effect of Nifedipine on aldose reductase delays cataract progression.
硝苯地平对醛糖还原酶的抑制作用可延缓白内障的进展。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):161-171. doi: 10.1007/s00210-023-02588-1. Epub 2023 Jul 3.
4
Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications.氨氯地平挽救血色素沉着症相关蛋白基因敲除小鼠模型中的晚期铁过载心肌病:临床意义。
Front Cardiovasc Med. 2023 Apr 21;10:1129349. doi: 10.3389/fcvm.2023.1129349. eCollection 2023.
5
Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors.新型双脲基取代的磺胺嘧啶和磺胺异噁唑类化合物作为碳酸酐酶和乙酰胆碱酯酶抑制剂。
Mol Divers. 2023 Aug;27(4):1735-1749. doi: 10.1007/s11030-022-10527-0. Epub 2022 Sep 22.
6
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.源自香草醛的新型酰腙类化合物作为潜在醛糖还原酶抑制剂的合成与表征
Mol Divers. 2023 Aug;27(4):1713-1733. doi: 10.1007/s11030-022-10526-1. Epub 2022 Sep 14.
7
Evaluating the Non-conventional Achalasia Treatment Modalities.评估贲门失弛缓症的非常规治疗方式。
Front Med (Lausanne). 2022 Jun 24;9:941464. doi: 10.3389/fmed.2022.941464. eCollection 2022.
8
Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif.一些新型 N-取代磺酰基酰胺的细胞毒性作用、酶抑制作用及计算机研究,这些酰胺含有 1,3,4-噁二唑结构基序。
Mol Divers. 2022 Oct;26(5):2825-2845. doi: 10.1007/s11030-022-10422-8. Epub 2022 Apr 9.
9
Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接的益肾胶囊治疗糖尿病肾病的潜在分子机制
Diabetes Metab Syndr Obes. 2022 Mar 29;15:943-962. doi: 10.2147/DMSO.S350062. eCollection 2022.